Prostate Cancer - Results from #26680

Fifth Joint Meeting of J-CaP and CaPSURE: Advancing the global understanding of prostate cancer and its management - Abstract January 31, 2012

MR-guided pulsed high intensity focused ultrasound enhancement of docetaxel combined with radiotherapy for prostate cancer treatment - Abstract January 31, 2012

Vanderbilt study finds prostate size may help predict cancer severity January 31, 2012

The HOPE fixation technique - a promising alternative to common prostate cancer biobanking approaches - Abstract January 30, 2012

18F-fluoride PET: Changes in uptake as a method to assess response in bone metastases from castrate-resistant prostate cancer patients treated with 223Ra-chloride (Alpharadin) - Abstract January 30, 2012

Short-term clinicopathological outcome of neoadjuvant chemohormonal therapy comprising complete androgen blockade, followed by treatment with docetaxel and estramustine phosphate before radical prostatectomy in Japanese patients with high-risk localized p January 30, 2012

A direct comparison of the diagnostic accuracy of three prostate cancer nomograms designed to predict the likelihood of a positive initial transrectal biopsy - Abstract January 30, 2012

A stochastic model for survival of early prostate cancer with adjustments for leadtime, length bias, and over-detection - Abstract January 30, 2012

Weight change and prostate cancer incidence and mortality - Abstract January 30, 2012

Sixteen-year longitudinal changes in serum prostate-specific antigen levels: The olmsted county study - Abstract January 30, 2012

Prostate cancer and inflammation: The evidence - Abstract January 30, 2012

Non-epithelial neoplasms of the prostate - Abstract January 30, 2012

Therapy-associated effects in the prostate gland - Abstract January 30, 2012

Anatomy of the prostate revisited: Implications for prostate biopsy and zonal origins of prostate cancer - Abstract January 30, 2012

Psychological aspects of prostate cancer: A clinical review - Abstract January 30, 2012

Adaptive image-guided radiotherapy (IGRT) eliminates the risk of biochemical failure caused by the bias of rectal distension in prostate cancer treatment planning: Clinical evidence - Abstract January 27, 2012

Phase II study of long-term androgen suppression with bevacizumab and intensity-modulated radiation therapy (IMRT) in high-risk prostate cancer - Abstract January 27, 2012

Reirradiation of paraaortic lymph node metastasis by brachytherapy with hyaluronate injection via paravertebral approach: With DVH comparison to IMRT - Abstract January 27, 2012

Evaluating the PCPT risk calculator in ten international biopsy cohorts: Results from the Prostate Biopsy Collaborative Group - Abstract January 27, 2012

Improving the reproducibility of the Gleason scores in small foci of prostate cancer - suggestion of diagnostic criteria for glandular fusion - Abstract January 27, 2012

Page 1335 of 1450